iTeos Therapeutics Statistics
Total Valuation
ITOS has a market cap or net worth of $448.68 million. The enterprise value is -$61.62 million.
| Market Cap | 448.68M |
| Enterprise Value | -61.62M |
Important Dates
The last earnings date was Wednesday, August 6, 2025, before market open.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ITOS has 44.21 million shares outstanding. The number of shares has increased by 17.71% in one year.
| Current Share Class | 44.21M |
| Shares Outstanding | 44.21M |
| Shares Change (YoY) | +17.71% |
| Shares Change (QoQ) | +0.75% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 68.04% |
| Float | 33.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.79 |
| P/TBV Ratio | 0.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.53, with a Debt / Equity ratio of 0.01.
| Current Ratio | 7.53 |
| Quick Ratio | 7.37 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -34.97% and return on invested capital (ROIC) is -21.76%.
| Return on Equity (ROE) | -34.97% |
| Return on Assets (ROA) | -18.49% |
| Return on Invested Capital (ROIC) | -21.76% |
| Return on Capital Employed (ROCE) | -36.78% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.17M |
| Employee Count | 173 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ITOS has paid $12.37 million in taxes.
| Income Tax | 12.37M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.53% in the last 52 weeks. The beta is 1.49, so ITOS's price volatility has been higher than the market average.
| Beta (5Y) | 1.49 |
| 52-Week Price Change | -41.53% |
| 50-Day Moving Average | 10.13 |
| 200-Day Moving Average | 8.29 |
| Relative Strength Index (RSI) | 54.76 |
| Average Volume (20 Days) | 1,639,705 |
Short Selling Information
The latest short interest is 2.06 million, so 4.66% of the outstanding shares have been sold short.
| Short Interest | 2.06M |
| Short Previous Month | 2.97M |
| Short % of Shares Out | 4.66% |
| Short % of Float | 6.16% |
| Short Ratio (days to cover) | 1.34 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -203.34M |
| Pretax Income | -102.48M |
| Net Income | -202.41M |
| EBITDA | -202.05M |
| EBIT | -203.34M |
| Earnings Per Share (EPS) | -$4.68 |
Balance Sheet
The company has $515.43 million in cash and $5.13 million in debt, giving a net cash position of $510.30 million or $11.54 per share.
| Cash & Cash Equivalents | 515.43M |
| Total Debt | 5.13M |
| Net Cash | 510.30M |
| Net Cash Per Share | $11.54 |
| Equity (Book Value) | 493.80M |
| Book Value Per Share | 12.90 |
| Working Capital | 458.72M |
Cash Flow
In the last 12 months, operating cash flow was -$108.06 million and capital expenditures -$630,000, giving a free cash flow of -$108.69 million.
| Operating Cash Flow | -108.06M |
| Capital Expenditures | -630,000 |
| Free Cash Flow | -108.69M |
| FCF Per Share | -$2.46 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ITOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.71% |
| Shareholder Yield | -17.71% |
| Earnings Yield | -45.11% |
| FCF Yield | -24.23% |
Analyst Forecast
The average price target for ITOS is $10.40, which is 2.46% higher than the current price. The consensus rating is "Hold".
| Price Target | $10.40 |
| Price Target Difference | 2.46% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -3.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ITOS has an Altman Z-Score of 1.23 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.23 |
| Piotroski F-Score | 1 |